The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Radhakrishnan, S.
Right arrow Articles by Pease, L. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Radhakrishnan, S.
Right arrow Articles by Pease, L. R.
The Journal of Immunology, 2007, 178: 3583-3592.
Copyright © 2007 by The American Association of Immunologists, Inc.

Induction of a Th1 Response from Th2-Polarized T Cells by Activated Dendritic Cells: Dependence on TCR:Peptide-MHC Interaction, ICAM-1, IL-12, and IFN-{gamma}1

Suresh Radhakrishnan*, Karla R. Wiehagen*, Vesna Pulko*, Virginia Van Keulen*, William A. Faubion*,{dagger}, Keith L. Knutson* and Larry R. Pease2,*

* Department of Immunology and {dagger} Division of Gastroenterology, Department of Internal Medicine, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905

Dendritic cells (DC) are important regulators of T cell immunity. The degree of stimulation, the pattern of costimulatory molecules expressed, and the cytokines secreted by DC dictate the nature of the effector and memory cells generated, particularly with respect to their Th1 or Th2 phenotypes. In this study, we demonstrate that the addition of activated DC to spleen cultures containing established Th2-polarized CD4+ T cells was sufficient to suppress Th2 and induce Th1 cytokines in a recall response, a phenomenon referred to as phenotype reversal. The ability of activated DC to induce phenotype reversal displayed exquisite Ag specificity. The DC activator B7-DC cross-linking Ab (XAb) was >10,000-fold more efficient at inducing phenotype reversal than the TLR agonists CpG-oligodeoxynucleotide and Gardiquimod. Characterization of the mechanisms governing phenotype reversal revealed the requirement for cognate interaction between the TCR:peptide-MHC complex, the expression of the costimulation/adhesion molecule ICAM-1, and secretion of IL-12 and IFN-{gamma} by the activated DC. The requirement for the costimulation/adhesion molecule SLAM (signaling lymphocytic activation molecule) was found to be quantitative. Thus, activation of DC, particularly by crosslinking B7-DC, can modulate well-established Th2 T cell responses in an Ag-specific manner. Because the regulation of mouse and human DC by B7-DC XAb overlaps in several significant ways, immune modulation with B7-DC XAb is a potential strategy for treating Th2-mediated diseases.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants CA96859, CA104996, and HL077296 (to L.R.P.) and DK64194 (to W.A.F.).

2 Address correspondence and reprint requests to Dr. Larry R. Pease, Department of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905. E-mail address: pease.larry{at}mayo.edu

3 Abbreviations used in this paper: DC, dendritic cell; CPG-ODN, CPG-containing oligodeoxynucleotide; int, intermediate; pI:C, polyinosinic:polycytidylic acid; SLAM, signaling lymphocytic activation module; XAb, cross-linking Ab.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Eljaafari, Y.-P. Li, and P. Miossec
IFN-{gamma}, as Secreted during an Alloresponse, Induces Differentiation of Monocytes into Tolerogenic Dendritic Cells, Resulting in FoxP3+ Regulatory T Cell Promotion
J. Immunol., September 1, 2009; 183(5): 2932 - 2945.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Rodriguez, A. E. Warrington, and L. R. Pease
Invited Article: Human natural autoantibodies in the treatment of neurologic disease
Neurology, April 7, 2009; 72(14): 1269 - 1276.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Wu, S. A. McClellan, R. P. Barrett, and L. D. Hazlett
{beta}-Defensin-2 Promotes Resistance against Infection with P. aeruginosa
J. Immunol., February 1, 2009; 182(3): 1609 - 1616.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Radhakrishnan, L. N. Arneson, J. L. Upshaw, C. L. Howe, S. J. Felts, M. Colonna, P. J. Leibson, M. Rodriguez, and L. R. Pease
TREM-2 Mediated Signaling Induces Antigen Uptake and Retention in Mature Myeloid Dendritic Cells
J. Immunol., December 1, 2008; 181(11): 7863 - 7872.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Radhakrishnan, R. Cabrera, E. L. Schenk, P. Nava-Parada, M. P. Bell, V. P. Van Keulen, R. J. Marler, S. J. Felts, and L. R. Pease
Reprogrammed FoxP3+ T Regulatory Cells Become IL-17+ Antigen-Specific Autoimmune Effectors In Vitro and In Vivo
J. Immunol., September 1, 2008; 181(5): 3137 - 3147.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Spiekerkoetter, C. M. Alvira, Y.-M. Kim, A. Bruneau, K. L. Pricola, L. Wang, N. Ambartsumian, and M. Rabinovitch
Reactivation of {gamma}HV68 induces neointimal lesions in pulmonary arteries of S100A4/Mts1-overexpressing mice in association with degradation of elastin
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L276 - L289.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.